Canakinumab is prescribed for:
- Cryopyrin-associated periodic syndromes (CAPS)
- Systemic juvenile idiopathic arthritis
- Frequent gout flares
- Tumor necrosis factor receptor-associated periodic syndrome (TRAPS)
- Immunology autoinflammatory conditions
Generic Name: Canakinumab
Brand Names: Ilaris
Canakinumab is an IL-1β blocker for periodic fever syndromes, gout, and systemic juvenile idiopathic arthritis.
Canakinumab is prescribed for:
Common side effects:
Serious side effects:
Canakinumab is a monoclonal antibody that specifically binds and neutralizes IL-1β.
Given every 4-8 weeks depending on condition, much less frequent than anakinra.
Option for patients with frequent gout flares who cannot take NSAIDs, colchicine, or corticosteroids.
Learn more at MedlinePlus.
This medication is commonly used to treat or manage the following conditions:
Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.
Loading questions...
Have questions about Canakinumab? Get expert answers from Dr. Zimmer.
Privacy: Your questions are posted anonymously for your health privacy. Your name and email are only used for admin purposes.
Questions are reviewed before posting. You'll see your question and Dr. Zimmer's answer below once approved.